Day and welcome to the Oruka Therapeutics, Inc. Annual Meeting. Today's conference is being recorded. At this time, I'd like to turn the conference over to Dr. Lawrence Klein. Please go ahead.
Thank you. Welcome to Oruka Therapeutics 2026 Annual Meeting of Stockholders. I'm Lawrence Klein, Oruka's President and Chief Executive Officer, a member of the Board of Directors, and Chair of today's meeting. Thank you for joining us today. We're also joined today by two members of our Board of Directors, Carl Dambkowski, Kristine Ball, and Chris Martin. I would also like to introduce Paul Quinlan, Oruka's general counsel, who will serve as Inspector of Election and the secretary of this meeting. Additionally, representatives of our independent registered public accounting firm, PricewaterhouseCoopers, are also joining us today. This meeting will be conducted in accordance with the agenda and rules of conduct provided on the virtual meeting website. To ensure an informative, orderly, and constructive meeting, we ask that participants adhere to these rules. First, we will address the business items before the stockholders as outlined in the proxy statement.
Following any discussion and the vote on these items, we will conclude the meeting. You may vote your shares online at any time during this meeting before the closing of the polls. The polls opened at the start of the meeting and will close immediately after the presentation and discussion of today's proposals. I have an affidavit stating that the company's agents have certified that the proxy materials were made available to stockholders of record beginning on April 17, 2026. I received an oath signed by the Inspector of Election stating that he will faithfully execute his duties with strict impartiality. Our board set April 7, 2026 as the record date for this meeting. Only stockholders of record on that date are entitled to vote at the meeting.
As of that date, there were 50,196,914 shares of the company's common stock issued and outstanding, each entitled to one vote. The Inspector of Election has informed me that at least a majority of those shares are represented either virtually or by proxy for the meeting. A quorum is present, and we can proceed with the business of the meeting. I declare that this meeting is properly constituted and convened. The company's stockholders were asked to vote on three proposals, each of which is described in our proxy statement. The first matter to be considered is the election of the following Class II Director nominees to the board to serve until 2029 Annual Meeting of stockholders. Myself, Lawrence Klein, and Chris Martin.
The second matter to be considered is the ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. The third and final matter to be considered is to approve, on a non-binding advisory basis, the compensation of our named executive officers. We will now see if there are any questions or comments regarding these proposals. I can confirm that there are no questions on the proposals at this time. We will close the polls shortly. If you have previously voted, it is not necessary to vote again unless you wish to change your vote or you requested a legal proxy. Any stockholder who hasn't yet voted or wishes to change their vote should do so now by clicking on the voting button on the web portal and following the instructions.
Since everyone has had the opportunity to vote, I now declare the polls are closed. According to the preliminary results, each director nominee has been duly elected, the appointment of PricewaterhouseCoopers has been ratified, and the non-binding advisory vote on the compensation of our named executive officers has been approved. The final vote totals, including any votes validly received at this meeting, will be tabulated and filed with the SEC. This concludes the business of the meeting. There being no further business, the meeting is now adjourned. Thank you.
This concludes today's call. Thank you for your participation. You may now disconnect.